Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury - PubMed (original) (raw)
Comparative Study
. 2017 Jun;91(6):1482-1494.
doi: 10.1016/j.kint.2016.12.021. Epub 2017 Feb 22.
Affiliations
- PMID: 28237709
- DOI: 10.1016/j.kint.2016.12.021
Free article
Comparative Study
Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury
Yan Xie et al. Kidney Int. 2017 Jun.
Free article
Abstract
Proton pump inhibitor (PPI) use is associated with an increased risk of acute kidney injury (AKI), incident chronic kidney disease (CKD), and progression to end-stage renal disease (ESRD). PPI-associated CKD is presumed to be mediated by intervening AKI. However, whether PPI use is associated with an increased risk of chronic renal outcomes in the absence of intervening AKI is unknown. To evaluate this we used the Department of Veterans Affairs national databases to build a cohort of 144,032 incident users of acid suppression therapy that included 125,596 PPI and 18,436 Histamine H2 receptor antagonist (H2 blockers) consumers. Over 5 years of follow-up in survival models, cohort participants were censored at the time of AKI occurrence. Compared with incident users of H2 blockers, incident users of PPIs had an increased risk of an estimated glomerular filtration rate (eGFR) under 60 ml/min/1.73m2 (hazard ratio 1.19; 95% confidence interval 1.15-1.24), incident CKD (1.26; 1.20-1.33), eGFR decline over 30% (1.22; 1.16-1.28), and ESRD or eGFR decline over 50% (1.30; 1.15-1.48). Results were consistent in models that excluded participants with AKI either before chronic renal outcomes, during the time in the cohort, or before cohort entry. The proportion of PPI effect mediated by AKI was 44.7%, 45.47%, 46.00%, and 46.72% for incident eGFR under 60 ml/min/1.73m2, incident CKD, eGFR decline over 30%, and ESRD or over 50% decline in eGFR, respectively. Thus, PPI use is associated with increased risk of chronic renal outcomes in the absence of intervening AKI. Hence, reliance on antecedent AKI as warning sign to guard against the risk of CKD among PPI users is not sufficient as a sole mitigation strategy.
Keywords: acute kidney injury; chronic kidney disease; clinical nephrology.
Published by Elsevier Inc.
Comment in
- The Authors Reply.
Xie Y. Xie Y. Kidney Int. 2017 Aug;92(2):515-516. doi: 10.1016/j.kint.2017.05.010. Kidney Int. 2017. PMID: 28709603 No abstract available. - Proton pump inhibitors and chronic kidney disease.
Kamal F, Khan MA, Howden CW. Kamal F, et al. Kidney Int. 2017 Aug;92(2):515. doi: 10.1016/j.kint.2017.04.037. Kidney Int. 2017. PMID: 28709604 No abstract available. - PPI: Niereninsuffizienz auch ohne Vorstufe.
Weyrich P. Weyrich P. MMW Fortschr Med. 2018 Jan;160(1):37. doi: 10.1007/s15006-018-0087-y. MMW Fortschr Med. 2018. PMID: 29335947 Review. German. No abstract available.
Similar articles
- Proton Pump Inhibitors and Risk of Incident CKD and Progression to ESRD.
Xie Y, Bowe B, Li T, Xian H, Balasubramanian S, Al-Aly Z. Xie Y, et al. J Am Soc Nephrol. 2016 Oct;27(10):3153-3163. doi: 10.1681/ASN.2015121377. Epub 2016 Apr 14. J Am Soc Nephrol. 2016. PMID: 27080976 Free PMC article. - Proton Pump Inhibitors and Risk of Acute and Chronic Kidney Disease: A Retrospective Cohort Study.
Hart E, Dunn TE, Feuerstein S, Jacobs DM. Hart E, et al. Pharmacotherapy. 2019 Apr;39(4):443-453. doi: 10.1002/phar.2235. Epub 2019 Mar 21. Pharmacotherapy. 2019. PMID: 30779194 Free PMC article. - Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.
Lazarus B, Chen Y, Wilson FP, Sang Y, Chang AR, Coresh J, Grams ME. Lazarus B, et al. JAMA Intern Med. 2016 Feb;176(2):238-46. doi: 10.1001/jamainternmed.2015.7193. JAMA Intern Med. 2016. PMID: 26752337 Free PMC article. - Associations of Proton-Pump Inhibitors and H2 Receptor Antagonists with Chronic Kidney Disease: A Meta-Analysis.
Wijarnpreecha K, Thongprayoon C, Chesdachai S, Panjawatanana P, Ungprasert P, Cheungpasitporn W. Wijarnpreecha K, et al. Dig Dis Sci. 2017 Oct;62(10):2821-2827. doi: 10.1007/s10620-017-4725-5. Epub 2017 Aug 23. Dig Dis Sci. 2017. PMID: 28836158 Review. - A Meta-analysis of the Association of Estimated GFR, Albuminuria, Diabetes Mellitus, and Hypertension With Acute Kidney Injury.
James MT, Grams ME, Woodward M, Elley CR, Green JA, Wheeler DC, de Jong P, Gansevoort RT, Levey AS, Warnock DG, Sarnak MJ; CKD Prognosis Consortium. James MT, et al. Am J Kidney Dis. 2015 Oct;66(4):602-12. doi: 10.1053/j.ajkd.2015.02.338. Epub 2015 May 11. Am J Kidney Dis. 2015. PMID: 25975964 Free PMC article. Review.
Cited by
- Proton pump inhibitors may increase the risk of cisplatin-induced acute kidney injury in patients with nasopharyngeal carcinoma: a prospective cohort study.
Luo H, Yi G, Tang H, Chen L, Hu L, Yang D, Chen Z, Li H, Zhan D, Yu Y, Zeng Y, Cai Y, Wu J, Liu H. Luo H, et al. Sci Rep. 2024 Aug 13;14(1):18839. doi: 10.1038/s41598-024-69821-6. Sci Rep. 2024. PMID: 39138312 Free PMC article. - Association between preoperative proton pump inhibitor use and postoperative acute kidney injury in patients undergoing major surgery.
Zheng X, Zhou Q, Zhu Y, Xu L, Xu D, Lv J, Yang L. Zheng X, et al. Ren Fail. 2024 Dec;46(2):2379596. doi: 10.1080/0886022X.2024.2379596. Epub 2024 Aug 4. Ren Fail. 2024. PMID: 39099235 Free PMC article. - Association between Proton Pump Inhibitor Use and Risk of Incident Chronic Kidney Disease: Systematic Review and Meta-Analysis.
Ang SP, Chia JE, Valladares C, Patel S, Gewirtz D, Iglesias J. Ang SP, et al. Biomedicines. 2024 Jun 25;12(7):1414. doi: 10.3390/biomedicines12071414. Biomedicines. 2024. PMID: 39061988 Free PMC article. Review. - Multidisciplinary Consensus for Rationalizing the Use of Acid Suppressants in Children and Adults: CONFOR.
Prabhoo RY, Pai UA, Wadhwa A, Pillai BV, D'souza C, Wadhawan M, Bhatnagar M, Prabhoo MR, Shetty S, Seshadri VP, Bhatnagar S, Manchanda SC, Kher V. Prabhoo RY, et al. Euroasian J Hepatogastroenterol. 2024 Jan-Jun;14(1):99-119. doi: 10.5005/jp-journals-10018-1430. Euroasian J Hepatogastroenterol. 2024. PMID: 39022200 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous